Evidence map›Paper›PMID 21487789›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2011

Barrier protective effects of lycopene in human endothelial cells.

Jae Woan Bae, Jong-Sup Bae

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. A New Target in Inflammatory Diseases: Lycopene.The Eurasian journal of medicine · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Bioactivities of phytochemicals present in tomato.Journal of food science and technology · 2018
    Review
  11. Lycopene and Vascular Health.Frontiers in pharmacology · 2018
    Review
  12. Carotenoids: biochemistry, pharmacology and treatment.British journal of pharmacology · 2017
    Review
  13. Article
  14. Anti-inflammatory effects of vicenin-2 and scolymoside on polyphosphate-mediated vascular inflammatory responses.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2016
    Article
  15. Review
  16. Article
  17. Anti-inflammatory effects of vicenin-2 and scolymoside in vitro and in vivo.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Article
  18. Article
  19. Inhibitory effects of polyozellin from Polyozellus multiplex on HMGB1-mediated septic responses.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jae Woan BaeDepartment of Biological Science, College of Life Science and Bioengineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 305-701, Republic of Korea.
Jong-Sup Bae
Korea Advanced Institute of Science and Technology · KRKyungpook National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIM AND

objectiveLycopene has antioxidant and anticancer effects but its barrier protective effects and underlying mechanism are not fully identified. The potential barrier protective roles of lycopene in lipopolysaccharide (LPS)-activated primary human umbilical vein endothelial cells (HUVECs) were investigated.

methodsWe determined the barrier protective effects of lycopene, such as permeability, leukocyte adhesion and migration, and activation of proinflammatory proteins in LPS-activated HUVECs.

resultsLycopene inhibited vascular barrier permeability, expression of cell adhesion molecules, leukocyte adhesion and transendothelial migration in LPS-activated HUVECs. Further studies revealed that lycopene suppressed the production of tumor necrosis factor-alpha (TNF-α) and activation of nuclear factor-κB (NF-κB), CD14 and Toll-like receptor-4 (TLR4).

conclusionThese findings suggest that lycopene has barrier integrity activity, and inhibitory activity on cell adhesion and migration to endothelial cells by blocking the activation of NF-κB, CD14 and TLR4 expression and production of TNF-α, thereby endorsing its usefulness as therapy for vascular inflammatory diseases.

Indexed as

Anticarcinogenic AgentsCapillary PermeabilityCarotenoidsCell AdhesionCell Adhesion MoleculesCell MovementEndothelial CellsHumansLipopolysaccharide ReceptorsLipopolysaccharidesLycopeneNeutrophilsNF-kappa BToll-Like Receptor 4Transendothelial and Transepithelial MigrationTumor Necrosis Factor-alphaAnticarcinogenic AgentsCarotenoidsCell Adhesion MoleculesLipopolysaccharide ReceptorsLipopolysaccharidesLycopeneNF-kappa BToll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID21487789
OpenAlexW2086733600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.